Transcription of Staphylococcus aureus ustrAliAn G AntimicrobiAl …
{{id}} {{{paragraph}}}
Example: stock market
Staphylococcus aureus ustrAliAn G AntimicrobiAl …
E244 CDI Vol 40 No 2 2016 Annual reports Australian Staphylococcus aureus Sepsis Outcome Programme, 2014 AbstractFrom 1 January to 31 December 2014, 27 institu-tions around Australia participated in the Australian Staphylococcal Sepsis Outcome Programme (ASSOP). The aim of ASSOP 2014 was to deter-mine the proportion of Staphylococcus aureus bacteraemia (SAB) isolates in Australia that are AntimicrobiAl resistant, with particular emphasis on susceptibility to methicillin and to characterise the molecular epidemiology of the isolates. Overall, of the 2,206 SAB episodes were methicillin resistant, which was significantly higher than that reported in most European countries. The 30-day all-cause mortality associated with methicillin-resistant SAB was , which was significantly higher than the mortality associated with methicillin-sensitive SAB (P< ).
E246 CDI Vol 40 No 2 2016 Annual reports Australian Staphylococcus aureus Sepsis Outcome Programme, 2014 SAB mortality was 23.4% (95% CI 19.1 to 28.1),
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Guidelines, Trimoxazole, DRUGS TO AVOID IN G6PD DEFICIENCY, Service Availability andReadiness, Service Availability and Readiness Assessment SARA, Zone diameter breakpoints for Streptococcus pneumoniae, Mueller Hinton Agar, Cause photoallergic, photosensitive and phototoxic reactions, DMARD MONITORING GUIDELINES – FOR GP, DMARD MONITORING GUIDELINES – FOR GP INFORMATION